Berenberg announced UDG Healthcare PLC (LON:UDG), bumping up its stock price target to 700.00GBX today
- Updated: October 6, 2016
In a report released on 10/07/2016 Berenberg upped the price target of UDG Healthcare PLC (LON:UDG) from 655.00GBX to 700.00GBX reporting a potential upside of 0%.
On Friday September 30, 2016, Jefferies International released a statement about UDG Healthcare PLC (LON:UDG) upped the target price from 680.00GBX to 720.00GBX that suggested an upside of 0%.
Boasting a price of 0.00GBX, UDG Healthcare PLC (LON:UDG) traded -0.15% lower on the day. With the last close down 7.24% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. UDG Healthcare PLC has recorded a 50-day average of 631.53GBX and a two hundred day average of 602.83GBX. Volume of trade was down over the average, with 413,036 shares of UDG changing hands under the typical 506,709
See Chart Below
UDG Healthcare PLC has a 52 week low of 452.20GBX and a 52 week high of 663.00GBX with a P/E ratio of 21.84 The company’s market cap is currently 0 GBX.
In addition to Berenberg reporting its target price, a total of 6 firms have issued a report on UDG. The one year target is 9.00GBX with one analyst rating the company a strong buy, six analysts rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and lastly zero equity analysts rating the company a sell.
Brief Synopsis About UDG Healthcare PLC (LON:UDG)
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries. The Sharp Packaging Services segment is engaged in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, and also provides Track and Trace serialization services. The Supply Chain Services segment includes Aquilant, a provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.